Impact of platinum complexes on dihydropyrimidine dehydrogenase activity in 5-fluorouracil-treated patients.
Magné
N
N
Pivot
X
X
Etienne-Grimaldi
M C
MC
François
E
E
Renée
N
N
Thyss
A
A
Schneider
M
M
Demard
F
F
Milano
G
G
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002945:Cisplatin / Q000008:administration & dosage* / Q000009:adverse effects; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D042943:Dihydrouracil Dehydrogenase (NADP); D004347:Drug Interactions; D005472:Fluorouracil / Q000008:administration & dosage* / Q000009:adverse effects; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D010088:Oxidoreductases / Q000187:drug effects / Q000378:metabolism*; D011379:Prognosis; D011446:Prospective Studies; D012494:Sampling Studies; D016896:Treatment Outcome
D010088:Oxidoreductases; D042943:Dihydrouracil Dehydrogenase (NADP); D002945:Cisplatin; D005472:Fluorouracil